Company intelligence / Profile preview

NeuroTheryX

Richmond Hill, Ontario, Canadadrinkzerodb.com ↗

Ownership: Private
Employees: ~4
Development stage: Preclinical

Overview

NeuroTheryX has developed a proprietary phenotype-based drug discovery platform focused on CNS and neurological indications. The company is developing small molecule therapeutics and nutraceuticals using genetic targets and mechanism-of-action approaches. It has established a diverse pipeline but specific clinical results are not publicly disclosed.

Therapeutic areas: Rare DiseasesImmunologyNeurology
Modalities: Small moleculesNatural extracts / nutraceuticals
Industry: Biotech

Partnerships

Cyclica Inc. (AI-driven drug discovery partnership/NineteenGale JV)JLABS Toronto residency program

Beyond the preview

Go deeper on NeuroTheryX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroTheryX.

Explore the full profile